HR8380-118

Introduced

To criminalize fraudulent statements made with respect to clinical vaccine trials.

118th Congress Introduced May 14, 2024

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Criminal Justice, Technology.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H90A4DBC8C917474FA9246C1494F56572: 1. Short title This Act may be cited as the Vaccines In Trial And Liability Act of 2024 or the VITAL Act of 2024.
  • Section H3039067FBF8341AA8CA06CEC5FBF08E7: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: 1041.Clinical vaccine trial...
  • Section HB54D9781EEFC4953AAF8CFD08286D567: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or...
  • Section HE0B4527CDC424E9CB980CD6C99A3566A: 3. Scope of authorization Section 564(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(c)) is amended— in paragraph (4), by striking and by...
  • Section H352D05A4DC814D3C91F4D1674BC19DE8: 4. Revision and revocation Section 564(g)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(g)(2)) is amended— in subparagraph (B), by...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Criminal Justice, Technology

Primary Purpose

This bill, To criminalize fraudulent statements made with respect to clinical vaccine trials., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Criminal Justice Technology

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
May 14, 2024

Mr. Green of Tennessee introduced the following bill; which was …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Criminal Justice Technology
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology